Psychedelic-Assisted Group Therapy: A Systematic Review [PDF]
Journal of Psychoactive Drugs, 2019 Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation.
Alexander Tropé +2 more
exaly +7 more sources
Older adults in psychedelic-assisted therapy trials: A systematic review [PDF]
Journal of PsychopharmacologyIntroductionGrowing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and ...
Lisa Bouchet +2 more
exaly +6 more sources
Perceptions of psychedelic-assisted therapy among Black Americans [PDF]
Journal of Mood & Anxiety Disorders, 2023 The present study investigated differences in perceptions of psychedelic-assisted therapy between Black and White Americans, as well as factors that may influence these perceptions. A final sample of 294 adults (42% female, 44% Black/African American or Mixed Race (of Black/African ancestry), 56% White American; Mage = 36.3 years) completed an online ...
Sierra Carter +2 more
exaly +4 more sources
Radiation therapy patients’ interest in psychedelic-assisted therapy: results of a survey [PDF]
Radiation OncologyBackground Comorbid mental health symptoms impact 30–40% of cancer patients, significantly compromising treatment adherence and increasing mortality rates.
Jino Park +8 more
doaj +4 more sources
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program [PDF]
Neuroscience AppliedThis article describes the Swiss limited access program for psychedelic/3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy. The Swiss Federal Office of Public Health can issue authorizations for the limited medical use of otherwise prohibited ...
Matthias E. Liechti +5 more
doaj +3 more sources
Psychedelic-assisted therapy for people with gambling disorder? [PDF]
J Behav AddictAbstractGambling disorder is a severe mental health and behavioural problem with harmful consequences, including financial, relationship and mental health problems. The present paper initiates discussion on the use of psychedelics combined with psychotherapeutic support as a potential treatment option for people living with a gambling disorder.
Romero P +3 more
europepmc +5 more sources
Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy. [PDF]
Clin Pharmacol TherPsychedelics have recently re‐emerged as potential treatments for various psychiatric conditions that impose major public health costs and for which current treatment options have limited efficacy. At the same time, personalized medicine is increasingly being implemented in psychiatry to provide individualized drug dosing recommendations based on ...
Halman A +5 more
europepmc +4 more sources
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy [PDF]
Frontiers in PsychologyJonathan Shedler +2 more
exaly +5 more sources
Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective [PDF]
Journal of Eating DisordersPsychedelic-assisted therapy (PAT) is an emerging intervention in psychiatry, for which there is preliminary evidence for effectiveness in eating disorders (EDs).
Elena Koning +6 more
doaj +3 more sources
Frontiers in Psychiatry, 2021 Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield +2 more
doaj +2 more sources